$265 Million is the total value of Krensavage Asset Management, LLC's 22 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $31,804,000 | +145.0% | 706,908 | +66.7% | 12.00% | +102.9% |
| UTHR | Buy | UNITED THERAPEUTICS CORP | $25,894,000 | +14.8% | 148,858 | +13.8% | 9.77% | -4.9% |
| IPXL | Buy | IMPAX LABORATORIES INC | $20,915,000 | +8.6% | 455,475 | +10.8% | 7.89% | -10.1% |
| TEVA | Buy | TEVA PHARMACEUTICAL-SP ADR | $18,319,000 | +18.5% | 309,962 | +24.9% | 6.91% | -1.9% |
| HYH | Buy | HALYARD HEALTH INC | $17,668,000 | +18.1% | 436,243 | +43.4% | 6.66% | -2.2% |
| OFIX | Buy | ORTHOFIX INTERNATIONAL NV | $17,337,000 | +56.0% | 523,447 | +69.0% | 6.54% | +29.2% |
| SCMP | Buy | SUCAMPO PHARMACEUTICALS-CL A | $15,894,000 | +9.4% | 967,404 | +3.6% | 5.99% | -9.4% |
| CNMD | Buy | CONMED CORP | $15,466,000 | +21.9% | 265,428 | +5.6% | 5.83% | +1.0% |
| Buy | INDIVIOR PLC | $15,258,000 | +441.6% | 4,318,944 | +331.9% | 5.76% | +348.6% | |
| MRK | Buy | MERCK & CO. INC. | $12,644,000 | +5.1% | 222,103 | +6.1% | 4.77% | -13.0% |
| RTIX | Buy | RTI SURGICAL INC | $11,435,000 | +36.0% | 1,770,072 | +4.0% | 4.31% | +12.7% |
| HRC | Buy | HILL-ROM HOLDINGS INC | $10,818,000 | +17.2% | 199,113 | +5.7% | 4.08% | -2.9% |
| Buy | AMGEN INC | $10,606,000 | +16.4% | 69,086 | +21.2% | 4.00% | -3.6% | |
| DEPO | Buy | DEPOMED INC | $7,788,000 | +1.2% | 362,887 | +5.6% | 2.94% | -16.2% |
| IVC | Buy | INVACARE CORP | $7,649,000 | +17.7% | 353,632 | +5.6% | 2.88% | -2.5% |
| AGN | New | ALLERGAN PLC | $7,068,000 | – | 23,290 | +100.0% | 2.67% | – |
| SPPI | New | SPECTRUM PHARMACEUTICALS INC | $5,771,000 | – | 843,702 | +100.0% | 2.18% | – |
| Buy | BIOTA PHARMACEUTICALS INC | $3,392,000 | +8.7% | 1,638,492 | +20.8% | 1.28% | -10.0% | |
| THRX | Buy | THERAVANCE INC | $3,077,000 | +21.4% | 170,308 | +5.7% | 1.16% | +0.5% |
| JNP | New | JUNIPER PHARMACEUTICALS INC | $2,998,000 | – | 327,617 | +100.0% | 1.13% | – |
| DRAD | Buy | DIGIRAD CORP | $1,923,000 | +0.9% | 443,099 | +5.6% | 0.72% | -16.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | 36 | Q3 2023 | 18.1% |
| Enanta Pharmceuticals Inc | 35 | Q3 2023 | 16.7% |
| INVACARE CORP | 28 | Q3 2021 | 5.8% |
| RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
| MCKESSON CORP | 20 | Q3 2022 | 16.3% |
| BIOGEN INC | 19 | Q3 2023 | 16.0% |
| MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
| DIGIRAD CORP | 18 | Q1 2019 | 1.0% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 16.1% |
| ALKERMES PLC | 16 | Q3 2023 | 14.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
| RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
| Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
| ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
| Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SCHEDULE 13G | 2024-02-27 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-17 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.